Cancer Research includes companies working on scientific research aimed at understanding the causes, prevention, diagnosis, treatment, and potential cures for cancer. It includes many disciplines, from biology and genetics, to clinical trials and drug development, with the ultimate goal of improving cancer care and outcomes. Cancer research companies are developing life-saving treatments and diagnostics for a growing market in high demand. These companies constantly innovate, have a global reach, and form important strategic partnerships, which makes them appealing to investors looking for profits and supporting health progress.
ViiV Releases Promising Phase 2 Data on Potential Long-acting HIV Drugs
Gilead Sciences Presented First Clinical Data For Its Investigational Once-Yearly Lenacapavir For HIV Prevention At CROI 2025 And Published In The Lancet
10 Health Care Stocks Whale Activity In Today's Session
Arvinas, Pfizer Breast Cancer Drug Fails To Show Progression-Free Survival Benefit In Trial
Sage Moved to Underperform at BofA; Says Biogen's Buyout Impact Has Passed
Gilead Sciences To Rally Around 11%? Here Are 10 Top Analyst Forecasts For Tuesday